Mechanistic research holds promise for bacterial vaccines and phage therapies for <i>Pseudomonas aeruginosa</i>.

aeruginosa accounts for 10.1% of nosocomial infections, making it a highly significant bacterium in hospital settings. 2 Because of P. aeruginosa’s ubiquitous nature and extremely complex genomic diversity, scientists have put earnest effort into developing effective vaccines over the years, but the results are not so encouraging. 3 Thus far, a number of vaccine candidates for P. aer

also in 132,142 other papers